ArticlePloS one2020

Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study.

Samuel Kembou Nzale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.